Endocrine disorders in Kearns-Sayre syndrome with different severity of symptoms: two case reports and a literature review

Kearns-Sayre Syndrome (KSS) is a variant of mitochondrial disorder caused by a Mitochondrial Deoxyribonucleic Acid (mtDNA) deletion. Clinical manifestations of KSS can include different organ and system involvement. Different organ malfunctions, more often cardiac dysfunction, can lead to death. No...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of translational myology
Main Authors:	Amergoolov, Ilya I., Khruleva, Yulia I., Pavlova, Maria G., Likhodey, Natalia V., Sulaev, Abu M., Surkova, Elena V., Sych, Yulia P., Kalashnikova, Marina F., Arustamyan, Anna S., Martirosyan, Gratsinna A., Lew-Gor, Simione T.
Format:	Journal Article
Language:	English
Published:	PAGEPress Publications 30-10-2024
Subjects:	Bone Mineral Density diabetes mellitus Hyperparathyroidism mitochondrial disorders Vitamin D
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Kearns-Sayre Syndrome (KSS) is a variant of mitochondrial disorder caused by a Mitochondrial Deoxyribonucleic Acid (mtDNA) deletion. Clinical manifestations of KSS can include different organ and system involvement. Different organ malfunctions, more often cardiac dysfunction, can lead to death. No effective treatment of this condition exists to date. Here, we report two patients with KSS. Female patient with a large-scale deletion of 7,020 base pairs (bp) suffered from hypogonadism, diabetes mellitus with fluctuating glucose levels, and had poor general health. A male patient with a common 4,977 bp deletion did not have diabetes mellitus but had impaired glucose tolerance. He also had a higher level of general health than our female patient. Both patients had reduced Bone Mineral Density (BMD). In female patients, calcium and vitamin D supplementation combined with metabolic therapy and nutritional drink supplements helped increase BMD (up to 32% in L1-L4). Comparing these two patients suggests that the larger the mtDNA deletion is, the more severe the course of the disease is. Not only does the size of the mtDNA deletion probably determine the severity of the disease, but also such factors as mtDNA heteroplasmy level, presence of mtDNA duplications, and pleioplasmy. Moreover, continuous nonconsecutive metabolic therapy and nutritional supplements are helpful in the prevention of deterioration of symptoms and general health.
ISSN:	2037-7452 2037-7460
DOI:	10.4081/ejtm.2024.12897